3 ms·
This is a really bad idea on every level. First, targeting spread instead of severity. This is not good. The amount of people that would fit the profile from a
by sudosysgen 6y ago
This is a really bad idea on every level.
First, targeting spread instead of severity. This is not good. The amount of people that would fit the profile from any available variables of a spreader are probably around 100 million in the US. If you're going to vaccinate most of them, you're going to need so many doses that you can vaccinate literally everyone that has over 0.2% fatality risk, and a month or two later you can reach herd immunity. There is clearly very little advantage there.
And for selling them on the free market, it's insane to expect that vaccine sellers with limited capacity will sell the vaccine for anywhere near an affordable price. You don't have nearly enough demand elasticity to justify the manufacturers - two of them, by the way, to drop their prices at all, because even if they sold them for 5000$ they would sell every dose they could produce for months. By the time they would be affordable for the average person, we could again have vaccinated all vulnerable people and a few months later essentially everyone.
In the two or three months between full vaccination of privileged classes and herd immunities, there will not be new mutations that will be able to spread despite full vaccination.